Allarity Therapeutics Announces 1-for-20 Reverse Stock

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...

Related Keywords

Denmark ,Thomas Pedersen ,Allarity Therapeutics Inc ,Company Contact ,Company Certificate Of Incorporation ,Company Board Of Directors ,Carrotize Pr Communications ,Linkedin ,Nasdaq ,Exchange Commission ,Allarity Therapeutics ,Reverse Stock Split ,Special Meeting ,Stock Split ,Reverse Stock ,Computershare Limited ,Drug Response Predictor ,Companion Diagnostic ,Private Securities Litigation Reform Act ,Nasdaq Allr ,Nc ,